ESR1 and breast cancer: Although all tumor tissues selected for this study were ERα+, due to the heterogeneity of breast cancer, we would determine if the other subtype of estrogen receptor (e.g., ERβ) as well as the seven uncanonical membrane-spanning estrogen receptor (e.g., GPER), were involved in NGB accumulation in cancer tissues.